Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oco, formerly known as Carbon Upcycling, is a biotechnology and materials science company that specializes in the utilization of captured carbon dioxide to create sustainable products. The company employs a proprietary electrochemical process to convert CO2 into high-value solid materials, such as additives for concrete, plastics, and consumer goods. By integrating biological and chemical engineering, Oco aims to reduce the carbon footprint of industrial manufacturing while providing high-performance alternatives to traditional materials. Their technology serves as a scalable solution for carbon sequestration and circular economy initiatives across multiple sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oco.